Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-17-012367
Filing Date
2017-01-18
Accepted
2017-01-18 16:30:56
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 13D d300763dsc13d.htm SC 13D 28349
2 EX-99.A d300763dex99a.htm EX-99.A 150840
3 EX-99.B d300763dex99b.htm EX-99.B 41447
  Complete submission text file 0001193125-17-012367.txt   222018
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Subject) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-77935 | Film No.: 17533783
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12575 ULINE DRIVE PLEASANT PRAIRIE WI 53158
Business Address
Uihlein Richard E (Filed by) CIK: 0001694903 (see all company filings)

Type: SC 13D